Clinical Trials Directory

Trials / Completed

CompletedNCT04005742

The Biomarkers Of RIsk of Colorectal Cancer (BORICC) Follow-Up (BFU) Study

Status
Completed
Phase
Study type
Observational
Enrollment
47 (actual)
Sponsor
Newcastle University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Worldwide, colorectal cancer is the 3rd most common cancer; risk increases with age and is modified by lifestyle factors notably diet, physical activity and obesity. The BORICC Follow-Up (BFU) Study is a 12+ year follow-up of participants recruited to the Biomarkers of Risk of Colon Cancer (BORICC) Study. This longitudinal study will investigate associations between ageing and lifestyle factors and a panel of molecular biomarkers linked with colorectal cancer risk.

Detailed description

The BORICC Follow-Up (BFU) Study builds on the findings from the BORICC Study where the investigators observed associations between age and nutritional factors, including selenium and folate, and biomarkers of colorectal health. The BFU Study will investigate the relationships between ageing (12+ years) and such biomarkers longitudinally. It is anticipated that the project will produce novel data on (i) changes in biomarkers of colorectal cancer risk with age and (ii) the effects of obesity and lifestyle factors on biomarkers of colorectal cancer risk. These biomarkers include differentially expressed proteins, DNA methylation markers and inflammation markers.

Conditions

Timeline

Start date
2017-03-13
Primary completion
2018-06-08
Completion
2018-06-08
First posted
2019-07-02
Last updated
2019-07-02

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04005742. Inclusion in this directory is not an endorsement.